- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04376346
Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES (WYSE CHOICES)
April 15, 2024 updated by: University of Colorado, Denver
Fetal Alcohol Syndrome Disorders (FASD) result in lifelong disability and are a leading cause of preventable birth defects in the US.
Urban American Indian and Alaska Native (AIAN) young women are at high risk for alcohol exposed pregnancies (AEPs) which can cause FASD.
In this project, the inverstigators will test the effectiveness of a culturally adapted mobile health intervention to prevent AEP, using social media to recruit AIAN young women from urban centers across the nation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed project builds on a prior NIAAA-funded project which used intensive community-based participatory research (CBPR) methods to adapt CHOICES, an evidence-based brief alcohol-exposed pregnancy (AEP) prevention intervention supported by the CDC, to American Indian Youth CHOICES (AIY-C).
AIY-C contains features that make it highly amenable to mHealth approaches, including a framework for integrating diverse cultural teachings, few modules of short duration, and concrete opportunities for goal-setting and achievement.
Innovative for this population is the plan to recruit young AIAN women from major urban areas in the US through social media-and to deliver AIY-C via mobile devices, increasingly ubiquitous among AIAN young adults.
While social media recruitment and mHealth interventions are not new, only very recently have they been used with AIAN populations.
The investigators will partner with urban AIAN organizations to guide us through social media recruitment strategies, mHealth intervention translation and implementation, and evaluation in urban AIAN settings.
The investigators propose 3 specific aims: (1) Develop and pilot social-media-based recruitment strategies for urban AIAN young women; (2) translate AIY-C for mHealth delivery through an iterative and theoretically driven process and pilot the developed translated mHealth AIY-C intervention; and (3) recruit 700 (final N=525) urban AIAN young women using identified social media strategies, and conduct an RCT to rigorously evaluate the effectiveness of the mHealth translation of AIY-C for preventing AEP and FASD.
Study Type
Interventional
Enrollment (Actual)
439
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Carol Kaufman, PhD
- Phone Number: 3038807795
- Email: carol.kaufman@cuanschutz.edu
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado- Anschutz Medical Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Identifies as American Indian or Alaska Native (AIAN)
- Biologically female
- 16-20 years old
- Not pregnant
- Not living in tribal reservation or in an Alaska Native Village
- Live in an urban area that is at least 50,000 in population
- Not breastfeeding
- Has an email account
- Has a smart phone
Exclusion Criteria:
- Age 15 or younger, and 21 or older
- Biologically male
- Not AIAN
- Pregnant or breastfeeding women
- People who live on a tribal land or in communities with less than 50,000 in population
- Reside in the state of Alaska (until study obtains local IRB approval)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Arm
Participants in the intervention arm will complete the AIY-C curriculum that has been translated for mHealth delivery.
This includes completing various activities such as completing their own risk assessment when it comes to AEP and setting goals for themselves.
|
Native WYSE (Women, Young, Strong, and Empowered) CHOICES (Changing High-risk alcohOl use and Increasing Contraception Effectiveness Study) is an alcohol-exposed pregnancy prevention program that translates CHOICES, an evidence-based targeted intervention, into an mHealth universal intervention for young urban American Indian/Alaska Native (AI/AN) women ages 16-20.
|
No Intervention: Control Arm
Participants in the control arm will complete activities that are carefully designed under different topics than the intervention arm.
In this regard, participants will complete various activities such as quizzes, interactive games and videos.
The investigators will ensure that participants in both arms will spend similar time on completing the activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol Use
Time Frame: Baseline
|
Number of days in past 30 had at least one alcoholic drink.
|
Baseline
|
Alcohol Use
Time Frame: 2 months
|
Number of days in past 30 had at least one alcoholic drink.
|
2 months
|
Alcohol Use
Time Frame: 6 months
|
Number of days in past 30 had at least one alcoholic drink.
|
6 months
|
Alcohol Use
Time Frame: 12 months
|
Number of days in past 30 had at least one alcoholic drink.
|
12 months
|
Effective Contraceptive Use
Time Frame: Baseline
|
Effective contraceptive use (including abstinence), measured by past 30-day vaginal sexual abstinence or, if sexually active, 30 day use of effective contraception at intercourse.
|
Baseline
|
Effective Contraceptive Use
Time Frame: 2 months
|
Effective contraceptive use (including abstinence), measured by past 30-day vaginal sexual abstinence or, if sexually active, 30 day use of effective contraception at intercourse.
|
2 months
|
Effective Contraceptive Use
Time Frame: 6 months
|
Effective contraceptive use (including abstinence), measured by past 30-day vaginal sexual abstinence or, if sexually active, 30 day use of effective contraception at intercourse.
|
6 months
|
Effective Contraceptive Use
Time Frame: 12 months
|
Effective contraceptive use (including abstinence), measured by past 30-day vaginal sexual abstinence or, if sexually active, 30 day use of effective contraception at intercourse.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carol Kaufman, PhD, University of Colorado - Anschutz Medical Campus
- Principal Investigator: Michelle Sarche, PhD, University of Colorado - Anschutz Medical Campus
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 4, 2021
Primary Completion (Actual)
February 25, 2024
Study Completion (Actual)
February 25, 2024
Study Registration Dates
First Submitted
April 14, 2020
First Submitted That Met QC Criteria
May 4, 2020
First Posted (Actual)
May 6, 2020
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 15, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 18-0574
- R01AA025603 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Exposed Pregnancy
-
University of VirginiaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Minnesota and other collaboratorsNot yet recruitingSexual Behavior | Alcohol Use, Unspecified | Alcohol Exposed Pregnancy | Unplanned Pregnancies | Contraception UseUnited States
-
University of VirginiaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Exposed PregnancyUnited States
-
Centers for Disease Control and PreventionCompletedRisk for an Alcohol-Exposed Pregnancy | Hazardous Alcohol Use | Risk for Unintended PregnancyUnited States
-
Baylor UniversityWayne State University; University of Texas at AustinRecruitingRisk for an Alcohol-Exposed Pregnancy | Risk for Marijuana-Exposed Pregnancy | Risk for Substance-Exposed Pregnancy | HIV Risk | Sexually Transmitted Infection RiskUnited States
-
University of FloridaNational Aeronautics and Space Administration (NASA)CompletedMicrogravity Exposed Endothelial CellsUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Nationwide Children's HospitalCompletedExposed to AnesthesiaUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedOccupational Exposed Population
-
University Hospital, Clermont-FerrandCompleted
-
University of Wisconsin, MadisonCompletedChildren Exposed to Adverse ExperiencesUnited States
Clinical Trials on Native WYSE CHOICES
-
Washington State UniversityUniversity of Colorado, Denver; University of Minnesota; Sanford Research; Missouri...RecruitingAlcohol Drinking | Contraceptive Usage | Alcohol Use Complicating ChildbirthUnited States
-
Medtronic Heart ValvesCompletedTetralogy of Fallot | Congenital Heart DiseaseUnited States, Canada
-
Northeastern UniversityNational Institute of Nursing Research (NINR)CompletedRisk Behavior | HIV | Sexual Behavior | Chlamydia | Women's RoleUnited States
-
Johns Hopkins UniversityNational Institute on Aging (NIA); Medstar Health Research InstituteCompleted
-
University of PrimorskaElettra Synchrotron TriesteCompletedAsymptomatic ConditionSlovenia
-
University of Rhode IslandRecruitingAlcohol Drinking | Tobacco Use | Drug UseUnited States
-
University of FloridaNational Human Genome Research Institute (NHGRI)RecruitingSickle Cell Disease | Sickle Cell TraitUnited States
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); California...UnknownObesity | Weight Loss | Weight ControlUnited States
-
UConn HealthNational Institute of Environmental Health Sciences (NIEHS)Recruiting